Onconova Therapeutics, Inc. ONTX Cash Flow

Onconova therapeutics, inc. (ONTX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Operating activities:
Net loss
-18,995	-21,503	-21,407	-22,160	-22,920	-20,410	-20,966	-22,578	-20,841	-24,092	-23,332	-17,971	-20,768	-19,667	-11,028	-15,302	-18,896	-24,023	-40,607	-49,641	-57,446	-63,795	-65,031	-70,645	-66,427	-62,556	0	0	0
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
9	14	22	33	47	55	63	71	81	88	93	95	95	96	97	100	102	150	223	293	365	434	456	478	489	446	0	0	0
Change in fair value of warrant liabilities
-427	-63	-223	123	-358	-1,597	-1,366	-1,028	-3,989	-1,628	-2,719	-5,634	-2,168	-3,988	0	0	0	-	-	-	-	-20	-81	-49	-44	-42	0	0	0
Treasury note discount amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	0	0	0	-	-	-	-
Stock compensation expense
491	1,048	1,264	1,414	1,519	1,147	1,210	1,346	1,530	1,710	1,905	2,050	2,217	3,929	4,166	4,381	4,573	3,786	3,818	4,613	5,123	5,068	5,303	7,812	6,878	8,015	0	0	0
Changes in assets and liabilities:
Receivables
0	-	-	-	-	-24	-33	-161	351	28	-847	-1,914	-1,242	-1,473	-631	1,880	1,334	1,372	0	0	0	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
0	-	-	-	-	-60	-304	-166	-34	-768	-168	-264	-305	-244	-733	-769	-1,418	-1,234	-2,365	-1,486	-1,729	-1,220	-959	-2,536	1,735	2,662	0	0	0
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-75	0	0	0	-	-	-	-	-	-	-	-
Accounts payable
-151	232	260	-1,199	-2,007	-1,454	-479	961	1,627	863	1,365	2,880	2,111	1,902	881	-1,384	-561	-606	-2,195	-842	555	317	980	617	-941	-1,807	0	0	0
Accrued expenses and other current liabilities
-1,348	-378	-40	198	737	838	389	-156	-909	-1,047	-1,383	-2,111	130	653	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-226	-227	-227	-284	-341	-398	-455	-454	-455	-454	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-616	1,125	2,235	1,894	0	0	0
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-28	-44	-60	-37	0	0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-455	-8,455	-8,454	-8,455	-8,455	-454	-455	-454	-787	-2,530	-3,508	-3,986	-4,631	0	0	0
Net cash used in operating activities
-20,693	-20,831	-20,880	-24,073	-23,788	-22,696	-21,960	-22,204	-23,273	-23,820	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investing activities:
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-25,963	-31,238	-40,468	-45,790	-51,337	-57,648	-60,508	-61,685	-63,600	-61,384	0	0	0
Payments for purchase of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	228	316	358	397	609	0	0	0
Financing activities:
Proceeds from the sale of common stock and warrants, net of costs
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	40,000	0	0	0	-	-	-	-
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39,772	24,684	-15,348	-30,387	-40,599	0	0	0
Proceeds from the sale of common stock and warrants, net of costs
-	-	-	-	-	-	36,111	36,111	15,045	6,360	5,316	21,130	15,851	17,420	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of warrants
10,584	4,900	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	963	1,054	1,049	1,004	157	0	0	0
Net cash provided by financing activities
41,394	26,648	3,393	424	26,949	35,657	36,700	36,700	15,061	6,360	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of foreign currency translation on cash
-6	-6	-20	-9	-29	-15	-6	5	37	34	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
20,640	5,756	-17,563	-23,658	3,132	12,946	14,734	14,501	-8,175	-17,426	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	1,463	1,550	81,356	81,311	80,464	0	0	0
Effect of foreign currency translation on cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	-9	-10	-14	-43	-14	10	-5	-7	1	0	0	0
Net (decrease) increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	1,601	3,581	-12,540	-16,863	-23,783	0	0	0	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12,683	-21,518	0	0	0